Acute Blockage of Notch Signaling by DAPT Induces Neuroprotection and Neurogenesis in the Neonatal Rat Brain After Stroke

作者：Li, Zhongxia; Wang, Jiangping; Zhao, Congying; Ren, Keming; Xia, Zhezhi; Yu, Huimin; Jiang, Kewen^*

来源：Translational Stroke Research, 2016, 7(2): 132-140.

DOI：10.1007/s12975-015-0441-7

• N-[N-(3, 5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester
• Notch signaling
• Ischemia
• Neuroprotection
• Neurogenesis
• Angiogenesis

Notch signaling is critically involved in various biological events. Notch undergoes cleavage by the gamma-secretase enzyme to release Notch intracellular domain that will translocate into nucleus to result in expression of target gene. gamma-Secretase inhibitors have been developed as potential treatments for neurological degenerative diseases, but its effects against ischemic injury remain relatively uncertain. In the present study, we demonstrated that N-[N-(3, 5-difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl ester (DAPT), a gamma-secretase inhibitor not only rescued the cerebral hypoperfusion or ischemia neonatal rats from death, reduced apoptosis in penumbra, but also reduced brain infarct size. Furthermore, DAPT elicited some morphologic hallmarks such as neurogenesis and angiogenesis that related to the brain repair and functional recovery after stroke: increased accumulations of newborn cells in the peri-infarct region with a higher fraction of them adopting immature neuronal and glial markers instead of microglial markers on 5 days, enhanced vascular densities in penumbra at 14 days, and evident regulations of the gene profiles associated with neurogenesis in penumbral tissues. The current results suggest that DAPT is a potential neuroprotectants against ischemic injury in immature brain, and future treatment strategies such as clinical trials using gamma-secretase inhibitors would be an attractive therapy for perinatal ischemia.

• 出版日期2016-4
• 单位浙江大学